Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Health and Me on MSN9h
Yearly Jab For HIV Protection Is Now Almost HereA yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
The Montgomery Advertiser on MSN1d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
HIV is currently the only disease carrying a felony charge if someone knowingly transmits it to another person. The Senate ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
1don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
The Canadian Press on MSN2h
TPH saw ‘many deviations’ at gynecologist’s clinic with potential HIV, hepatitis exposureToronto Public Health says it observed “many deviations from best practices” during an inspection at the gynecologist's ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback